Skip to main content
oAv Menu
Home
Patient Care Center
Clinical Trials
Providers
Therapeutics
People
Places
Community Center
Community Stories
Social Media
Community Content
Financial Assistance
News
Community Events
Clinical Trials and Research
Business
News People
Happenings
Spotlight
Fundraising Events
Trusted Resources
Education
Videos & Visuals
Event Calendar
Login
Search
UPCOMING SESSIONS
in
ET
Thu, Oct 1, 2026
5:00 – 6:00 AM Bangkok
A Cardiologist’s Approach: How I Treat Cardiac Amyloidosis
Martha Grogan
Click Here To Register
View all
UPCOMING SESSIONS
in
ET
Thu, Oct 1, 2026 · 5:00 – 6:00 AM Bangkok
A Cardiologist’s Approach: How I Treat Cardiac Amyloidosis
Martha Grogan
Click Here To Register
View all sessions
All Upcoming Sessions
3
OCT
1
A Cardiologist’s Approach: How I Treat Cardiac Amyloidosis
Thu, Oct 1, 2026 · 5:00 – 6:00 AM Bangkok
Martha Grogan
Register
OCT
2
Navigating the Emotional Ups and Downs of Your Care Journey
Fri, Oct 2, 2026 · 5:00 – 6:00 AM Bangkok
Valentin Torres
Register
OCT
6
Medication Approvals & Navigating Insurance
Tue, Oct 6, 2026 · 5:00 – 6:00 AM Bangkok
David Plaza
Register
Alnylam Pharmaceuticals
Home
Alnylam Pharmaceuticals
Mar 20, 2025
RNAi Therapeutics Market Growth 2024-2025
Read more
Mar 17, 2025
Alnylam’s Amvuttra Expected to Make Three in Crowded ATTR-CM Space
Read more
Feb 25, 2025
Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day
Read more
Feb 25, 2025
Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day
Read more
Feb 15, 2025
Alnylam CEO: New administration ushers in great season of uncertainty
Read more
Jan 23, 2025
Alnylam Pharmaceuticals receives a prestigious "Tell Award" for business investment in Switzerland
Read more
Jan 12, 2025
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2024 Global Net Product Revenues and Provides 2025 Combined Net Product Revenue Guidance and Pipeline Goals
Read more
Alnylam's Helios B Trial Explained: A Plain Language Summary
Read more
Alnylam® Pharmaceuticals
Read more
Alnylam Pharmaceuticals - Linkedin
Read more
Subscribe to